Location History:
- Poway, CA (US) (2002)
- Schodack Landing, NY (US) (2006)
Company Filing History:
Years Active: 2002-2006
Title: Richard Christopher Oglesby: Innovator in Substituted Pyrazolopyrimidines
Introduction
Richard Christopher Oglesby is an esteemed inventor based in Schodack Landing, NY. With a strong focus on pharmaceutical innovations, he has made significant contributions to the field through his inventive prowess. Oglesby holds two patents that reflect his commitment to advancing medicinal chemistry.
Latest Patents
Oglesby's latest patents include advancements in the synthesis of substituted pyrazolopyrimidines. Specifically, he has developed methods for creating N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide. These compounds have broad utility, particularly in the treatment of insomnia. His work emphasizes improved techniques that eliminate the need for isolating the pyrazole intermediate. This innovation presents significant advantages in terms of efficiency, especially in large-scale manufacturing processes.
Career Highlights
Oglesby is currently employed at Neurocrine Biosciences, Inc., where he continues to drive innovation in the pharmaceutical sector. His career reflects a deep dedication to enhancing therapeutic solutions through chemical research and development.
Collaborations
Throughout his career, Richard has collaborated with talented individuals such as Raymond Stanley Gross and Keith M Wilcoxen. These partnerships have fostered a collaborative environment that nurtures creativity and facilitates the successful development of new compounds.
Conclusion
Richard Christopher Oglesby stands out as a prominent inventor in the realm of substituted pyrazolopyrimidines. His innovative contributions have the potential to transform therapeutic approaches, particularly in addressing sleep-related disorders. Oglesby's ongoing research and dedication to pharmaceutical advancements continue to shape the future of medicine.